DSHEA

October 25, 2021 marks the 27th anniversary of the Dietary Supplement Health and Education Act (DSHEA) being signed into law, establishing a regulatory framework for dietary supplements where no such system existed before.

It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.

CHPA's RSQ discussed issues including DSHEA Modernization, CBD, and product quality among hot topics at 2021 virtual conference.

Janet Woodcock, Cara Welch, other consumer healthcare leaders to discuss emerging trends in OTCs, dietary supplements, and consumer medical devices

Join pioneers Patricia Knight, Scott Bass, and Loren Israelsen as they share stories on the founding of DSHEA and why the industry can benefit from its modernization 27 years later.

Perhaps the most precious commodity on Capitol Hill is time. This is only exacerbated over the summer, when congressional recesses are common around the Fourth of July and then, again, in August. Therefore, when Congress is in, there is a scramble to address pressing concerns and “must pass” legislative issues.

The dietary supplements segment has just experienced its largest annual growth rate since 1997. Hear from Dr. Pieter Cohen as he shares his insights on how modernization of DSHEA will help improve category compliance and credibility.

Last week, CHPA, the American Herbal Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance sent a letter to Senators Tammy Baldwin (D-Wisc.) and John Hoeven (R-N.D.), the Chair and Ranking Member of the Appropriations Subcommittee that has jurisdiction over FDA funding, highlighting the need for additional resources for the Office of Dietary Supplement Programs at FDA due to the growing dietary supplement market.

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.